Skip to main navigation Skip to search Skip to main content

The glycosaminoglycan-binding domain of PRELP acts as a cell type-specific NF-kappa B inhibitor that impairs osteoclastogenesis

Nadia Rucci, Anna Rufo, Marina Alamanou, Mattia Capulli, Andrea Del Fattore, Emma Åhrman, Daria Capece, Valeria Iansante, Francesca Zazzeroni, Edoardo Alesse, Dick Heinegård, Anna Teti

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'The glycosaminoglycan-binding domain of PRELP acts as a cell type-specific NF-kappa B inhibitor that impairs osteoclastogenesis'. Together they form a unique fingerprint.
Sort by

Biochemistry, Genetics and Molecular Biology

Medicine and Dentistry

Immunology and Microbiology